- Home
- SRBK vs ANVS Comparison
SRBK vs ANVS Comparison
Compare SRBK & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRBK
- ANVS
- Stock Information
- Founded
- SRBK 1887
- ANVS 2008
- Country
- SRBK United States
- ANVS United States
- Employees
- SRBK N/A
- ANVS N/A
- Industry
- SRBK
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SRBK
- ANVS Health Care
- Exchange
- SRBK Nasdaq
- ANVS Nasdaq
- Market Cap
- SRBK 96.1M
- ANVS 110.4M
- IPO Year
- SRBK N/A
- ANVS 2020
- Fundamental
- Price
- SRBK $10.67
- ANVS $9.64
- Analyst Decision
- SRBK
- ANVS Strong Buy
- Analyst Count
- SRBK 0
- ANVS 6
- Target Price
- SRBK N/A
- ANVS $29.67
- AVG Volume (30 Days)
- SRBK 20.6K
- ANVS 341.4K
- Earning Date
- SRBK 01-01-0001
- ANVS 11-06-2024
- Dividend Yield
- SRBK N/A
- ANVS N/A
- EPS Growth
- SRBK N/A
- ANVS N/A
- EPS
- SRBK N/A
- ANVS N/A
- Revenue
- SRBK $22,814,000.00
- ANVS N/A
- Revenue This Year
- SRBK N/A
- ANVS N/A
- Revenue Next Year
- SRBK N/A
- ANVS N/A
- P/E Ratio
- SRBK N/A
- ANVS N/A
- Revenue Growth
- SRBK 52.54
- ANVS N/A
- 52 Week Low
- SRBK $8.01
- ANVS $4.53
- 52 Week High
- SRBK $11.24
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- SRBK 51.76
- ANVS 58.70
- Support Level
- SRBK $10.97
- ANVS $9.00
- Resistance Level
- SRBK $11.09
- ANVS $10.54
- Average True Range (ATR)
- SRBK 0.06
- ANVS 0.81
- MACD
- SRBK -0.05
- ANVS 0.12
- Stochastic Oscillator
- SRBK 5.50
- ANVS 74.57
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.